NCT00330915View on ClinicalTrials.gov

A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer.

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Rectal Neoplasms
Interventions
DRUG

pemetrexed

500 mg/m2, intravenous (IV), every 21 days x 3 cycles

Trial Locations (1)

41685

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Gothenburg

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00330915 - A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer. | Biotech Hunter | Biotech Hunter